8-F2-isoprostane, thioredoxin and thioredoxin reductase levels in children with obsessive–compulsive disorder

References

• Alici D, Bulbul F, Virit O. Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 2016;70:109–115.
   PubMed Web of Science ®Google Scholar
• Kandemir H, Abuhandan M, Aksoy N, et al. Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder. J Psychiatr Res. 2013;47:1831–1834.
   PubMed Web of Science ®Google Scholar
• Behl A, Swami G, Sircar SS, et al. Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology. 2010;61:210–214.
   PubMed Web of Science ®Google Scholar
• Ersan S, Bakir S, Erdal Ersan E, et al. Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1039–1042.
   PubMed Web of Science ®Google Scholar
• Ozdemir E, Cetinkaya S, Ersan S, et al. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:62–65.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.
   PubMed Web of Science ®Google Scholar
• Ng F, Berk M, Dean O, et al. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11:851–876.
   PubMed Web of Science ®Google Scholar
• Guldenpfennig M, Wolmarans de W, du Preez JL, et al. Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse. Physiol Behav. 2011;103:404–411.
   PubMed Web of Science ®Google Scholar
• Brennan BP, Jensen JE, Perriello C, et al. Lower posterior cingulate cortex glutathione levels in obsessive-compulsive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016;1:116–124.
   PubMedGoogle Scholar
• Li W, Mai X, Liu C. The default mode network and social understanding of others: what do brain connectivity studies tell us. Front Hum Neurosci. 2014;8:74.
   PubMed Web of Science ®Google Scholar
• Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124:1–38.
   PubMed Web of Science ®Google Scholar
• Yager S, Forlenza MJ, Miller GE. Depression and oxidative damage to lipids. Psychoneuroendocrinology. 2010;35:1356–1362.
   PubMed Web of Science ®Google Scholar
• Pratico D, Rokach J, Lawson J, et al. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem Phys Lipids. 2004;128:165–171.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhong S, Liao X, et al. A meta-analysis of oxidative stress markers in depression. PLoS One . 2015;10:e0138904.
   PubMed Web of Science ®Google Scholar
• Lee EE, Eyler LT, Wolkowitz OM, et al. Elevated plasma f2-isoprostane levels in schizophrenia. Schizophr Res. 2016;176:320–326.
   PubMed Web of Science ®Google Scholar
• Qasem H, Al-Ayadhi L, El-Ansary A. Cysteinyl leukotriene correlated with 8-isoprostane levels as predictive biomarkers for sensory dysfunction in autism. Lipids Health Dis. 2016;15:130.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Chen DC, Xiu MH, et al. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients. Schizophr Res. 2009;113:151–157.
   PubMed Web of Science ®Google Scholar
• Zhang QB, Gao SJ, Zhao HX. Thioredoxin: a novel, independent diagnosis marker in children with autism. Int J Dev Neurosci. 2015;40:92–96.
   PubMed Web of Science ®Google Scholar
• Al-Yafee YA, Al-Ayadhi LY, Haq SH, et al. Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. BMC Neurol. 2011;11:139.
   PubMed Web of Science ®Google Scholar
• Kondolot M, Ozmert EN, Asci A, et al. Plasma phthalate and bisphenol a levels and oxidant-antioxidant status in autistic children. Environ Toxicol Pharmacol. 2016;43:149–158.
   PubMed Web of Science ®Google Scholar
• El-Ansary A. Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients. Data Brief. 2016;7:111–116.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Bar-Or R, Rael LT, et al. Oxidative stress in severe acute illness. Redox Biol. 2015;4:340–345.
   PubMed Web of Science ®Google Scholar
• Gokler B, Unal F, Pehlivanturk B, et al. Reliability and validity of schedule for affective disorders and schizophrenia for school age children present and lifetime version—Turkish version (K-SADS-PL-T.). Turkish J Child Adolesc Psychiatry. 2004;11:109–116.
   Google Scholar
• Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL-T). Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980–988.
   PubMed Web of Science ®Google Scholar
• Rachman S, Hodgson RJ. Obsessions and compulsions. Englewood Cliffs, NJ: Prentice Hall; 1980.
   Google Scholar
• Erol N, Savaşır I. Maudsley obsesif kompulsif soru listesi. Proceedings of the 24. National Psychiatry and Neurological Science Congress; Ankara, Turkey; GATA Press; 1988. p. 107–114.
   Google Scholar
• Birmaher B, Brent DA, Chiappetta L, et al. Psychometric properties of the screen for child anxiety related emotional disorders (scared): a replication study. J Am Acad Child Adolesc Psychiatry. 1999;38:1230–1236.
   PubMed Web of Science ®Google Scholar
• Karaceylan F. Reliability and validity of scared in Turkish children: child and adolescent psychiatry. Kocaeli: Kocaeli University; 2005.
   Google Scholar
• Kuloglu M, Atmaca M, Tezcan E, et al. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology. 2002;46:27–32.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Singh OP, Dasgupta A, et al. Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:363–366.
   PubMed Web of Science ®Google Scholar
• Bas A, Gultekin G, Incir S, et al. Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics. Psychiatry Res. 2017;247:84–89.
   PubMed Web of Science ®Google Scholar
• Owe-Larsson B, Ekdahl K, Edbom T, et al. Increased plasma levels of thioredoxin-1 in patients with first episode psychosis and long-term schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1117–1121.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Chen DC, Xiu MH, et al. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls. Schizophr Res. 2013;143:301–306.
   PubMed Web of Science ®Google Scholar
• Genc A, Kalelioglu T, Karamustafalioglu N, et al. Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment. Psychiatry Clin Neurosci. 2015;69:344–350.
   PubMed Web of Science ®Google Scholar
• Aydin EP, Genc A, Dalkiran M, et al. Thioredoxin is not a marker for treatment-resistance depression but associated with cognitive function: An rTMS study. Prog Neuropsychopharmacol Biol Psychiatry. 2018;80:322–328.
   PubMed Web of Science ®Google Scholar
• Selek S, Herken H, Bulut M, et al. Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:487–491.
   PubMed Web of Science ®Google Scholar
• Şimşek Ş, Gençoğlan S, Yüksel T. DNA damage and antioxidants in treatment naive children with obsessive-compulsive disorder. Psychiatry Res. 2016;237:133–137.
   PubMed Web of Science ®Google Scholar
• Albert U, Aguglia A, Chiarle A, et al. Metabolic syndrome and obsessive-compulsive disorder: a naturalistic Italian study. Gen Hosp Psychiatry. 2013;35:154–159.
   PubMed Web of Science ®Google Scholar
• Isomura K, Brander G, Chang Z, et al. Metabolic and cardiovascular complications in obsessive-compulsive disorder: a total population, sibling comparison study with long-term follow-up. Biol Psychiatry. 2017; 3223:32286–32282.
   Google Scholar
• Jaisoorya TS, Janardhan Reddy YC, Nair BS, et al. Prevalence and correlates of obsessive-compulsive disorder and subthreshold obsessive-compulsive disorder among college students in Kerala, India. Indian J Psychiatry. 2017;59:56–62.
   PubMed Web of Science ®Google Scholar
• Chitty KM, Lagopoulos J, Hickie IB, et al. The impact of alcohol and tobacco use on in vivo glutathione in youth with bipolar disorder: an exploratory study. J Psychiatr Res. 2014;55:59–67.
   PubMed Web of Science ®Google Scholar
• Black CN, Bot M, Scheffer PG, et al. Sociodemographic and lifestyle determinants of plasma oxidative stress markers 8-ohdg and f2-isoprostanes and associations with metabolic syndrome. Oxid Med Cell Longev. 2016;2016:1.
   Web of Science ®Google Scholar
• Hosseini B, Saedisomeolia A, Allman-Farinelli M. Association between antioxidant intake/status and obesity: a systematic review of observational studies. Biol Trace Elem Res. 2017;175:287–297.
   PubMed Web of Science ®Google Scholar